- Chemed reported Q3 diluted EPS of $5.45 compared to $4.46 in the prior-year period.
- Adjusted EPS reached $6.75 versus $5.27 in the comparable quarter.
- Overall revenue and operating metrics reflected solid expansion across key segments.
?? Positive AI Sentiment (+5.0 / 10)